SCHEMBL9217138

SCHEMBL9217138

COCCOC(=O)C1=C(C)N(C)C(C)=C(C(=O)OC(C)C)C1c1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.51
NPSR1 Q6W5P4 4/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CACNA1F O60840 2/20 0.49
CACNA1D Q01668 2/20 0.49
CACNA1S Q13698 2/20 0.49
CACNA1C Q13936 2/20 0.49
KDM4E B2RXH2 3/20 0.49
GAA P10253 2/20 0.49
TSHR P16473 4/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
LMNA P02545 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23686215 0.91 HTT (0.53) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL9217355 0.89 HPGD (0.66) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL23686213 0.89 HTT (0.51) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL23686118 0.88 KDM4E (0.64) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL9119964 0.88 HTT (0.48) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL9222512 0.87 HTT (0.47) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL23686109 0.87 HTT (0.49) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL23686115 0.86 CACNA1F (0.66) HPGDSMN1; SMN2CACNA1FCACNA1DCACNA1S
SCHEMBL9220053 0.86 HTT (0.48) HTTNPSR1HPGDSMN1; SMN2CACNA1F
SCHEMBL23686108 0.85 HTT (0.50) HTTNPSR1HPGDSMN1; SMN2CACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525568-B1 N-Alkylated 1,4-dihydropyridine carboxylicacid ester derivatives BAYER AG (DE) 1995-05-10 EP claimed
US-5328931-A Nervous sytem disorders, cognition activators BAYER AKTIENGESELLSCHAFT (DE) 1994-07-12 US claimed
US-5328931-A Nervous sytem disorders, cognition activators BAYER AKTIENGESELLSCHAFT (DE) 1994-07-12 US disclosed